Original articleCentral Macular Splaying and Outer Retinal Thinning in Asymptomatic Sickle Cell Patients by Spectral-Domain Optical Coherence Tomography
Section snippets
Patient Selection
Twenty-one African-American female sickle cell patients (42 eyes) without history of ocular disease, aside from refractive error or sickle cell retinopathy, and 18 African-American female healthy control subjects (33 eyes) without clinical evidence of maculopathy by ophthalmic examination participated in the study. The ages and diagnoses of patients are listed in the Table. The average age of sickle cell patients (30 ± 2 years) was comparable to the control subjects (34 ± 2 years) (P = .20).
Results
A comparison of mean central total macular thickness (CMT, central 1 mm) in sickle cell patients and control subjects is shown in Figure 3. CMT was 220 ± 3 μm (mean ± standard error of the mean [SEM]), significantly lower than controls (228 ± 3 μm) (P < .05). Parafoveal regions (0.5 to 1.5 mm eccentricity) had thickness measurements of 314 ± 5 μm and 304 ± 2 μm at nasal and temporal regions, respectively, which were significantly lower than controls (327 ± 2 μm [nasal] and 311 ± 2 μm
Discussion
Patients with SCD suffer from manifestations of vascular occlusions in retinal tissue. Sickle cell retinopathy is known to cause retinal pathologies predominantly in the retinal periphery, but can also cause macular infarctions.11 These changes may cause changes in the thickness of retinal layers in the macula and reduce vision. To our knowledge, segmentation analysis of the alteration in the macular thickness in SCD retinopathy has not been reported. In the current study, thickness of the
Quan (Donny) Hoang, is a graduate of Northwestern University with majors in chemistry, biology and integrated science. He received his PhD and MD in 2006 from the University of Illinois at Chicago. His graduate research focused on the ionic and signal transduction mechanisms of sleep and arousal. He completed ophthalmology residency at the Illinois Eye and Ear Infirmary and is currently a Vitreo-Retinal Surgery fellow at Columbia University/Vitreous-Retina-Macula Consultants of NY in New York,
References (13)
- et al.
Ocular manifestations of sickle hemoglobinopathies
Surv Ophthalmol
(1977) Classification and pathogenesis of proliferative sickle retinopathy
Am J Ophthalmol
(1971)Isolated macular infarction in sickle cell (SS) disease
Am J Ophthalmol
(1972)- et al.
Peripapillary and macular vessel occlusions in sickle cell anemia
Am J Ophthalmol
(1973) - et al.
Normative data for macular thickness by high-definition spectral-domain optical coherence tomography (spectralis)
Am J Ophthalmol
(2009) - et al.
Binasal visual field defects from simultaneous bilateral retinal infarctions in sickle cell disease
Am J Ophthalmol
(2007)
Cited by (79)
Main nose-throat-ears, and ophthalmic features in sickle cell disease children
2023, Presse MedicaleChoriocapillaris: Fundamentals and advancements
2022, Progress in Retinal and Eye ResearchDiagnostic and Treatment Update on Sickle Cell Retinopathy
2021, Advances in Ophthalmology and OptometryCitation Excerpt :Other findings suggest the outer retina and choroid may not be entirely spared from ischemic insult, but any quantitative changes may not be clinically significant. This was demonstrated in a review of OCT findings in 21 asymptomatic patients with SCD who were noted to have central macular outer retinal thickness 10 μm thinner than controls [27]. In addition, choroidal thickness has been noted to be significantly thinner in patients with SCD than age-matched healthy controls suggesting outer retinal damage that remains subclinical [28].
Sickle Cell Maculopathy: Microstructural Analysis Using OCTA and Identification of Genetic, Systemic, and Biological Risk Factors
2021, American Journal of OphthalmologyRole of OCT-angiography in the management of sickle cell retinopathy
2020, Journal Francais d'Ophtalmologie
Quan (Donny) Hoang, is a graduate of Northwestern University with majors in chemistry, biology and integrated science. He received his PhD and MD in 2006 from the University of Illinois at Chicago. His graduate research focused on the ionic and signal transduction mechanisms of sleep and arousal. He completed ophthalmology residency at the Illinois Eye and Ear Infirmary and is currently a Vitreo-Retinal Surgery fellow at Columbia University/Vitreous-Retina-Macula Consultants of NY in New York, New York.